Literature DB >> 9407450

Predictors of end-stage renal disease and body mass index in a screened cohort.

K Iseki1, Y Ikemiya, K Fukiyama.   

Abstract

The effect of body mass index (BMI) on the risk of developing end-stage renal disease (ESRD) has not been critically evaluated. To investigate this issue we used the registries of community-based mass screening and chronic dialysis programs. In 1983, a total of 101,516 subjects (47,901 men and 53,615 women) participated in a mass screening program in Okinawa, Japan. A total of 187 (101 men and 86 women) entered an ESRD program by March 31, 1994. Body mass index was calculated as weight in kilograms divided by the square of the height in meters. Subjects were categorized into six groups based on BMI: < 20.0, 20.0-21.9, 22.0-23.9, 24.0-25.9, 26.0-27.9, and > or = 28.0 kg/m2. The cumulative incidence of ESRD, per 100,000 subjects was calculated in each BMI subgroup for men and women. In men, the cumulative incidence of ESRD increased with BMI, except in the range of 24.0 to 25.9 kg/m2. In women, the association between the cumulative incidence of ESRD and BMI was not clear, but was lowest in the range of 24.0 to 25.9 kg/m2. The adjusted odds ratio (95% confidence interval) was 0.99 (0.92 to 1.13) in men and 0.83 (0.72 to 0.96) in women.

Entities:  

Mesh:

Year:  1997        PMID: 9407450

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  10 in total

1.  Erythropoietin has a restorative effect on the contractility of arteries following experimental hypoxia.

Authors:  Sarah B Withers; Neha Passi; Alfred S Williams; Declan de Freitas; Anthony M Heagerty
Journal:  J Cardiovasc Dis Res       Date:  2013-10-16

2.  Possible Link between Metabolic Syndrome and Chronic Kidney Disease in the Development of Cardiovascular Disease.

Authors:  Kosaku Nitta
Journal:  Cardiol Res Pract       Date:  2010-10-07       Impact factor: 1.866

3.  Changes in body weight predict CKD in healthy men.

Authors:  Seungho Ryu; Yoosoo Chang; Hee-Yeon Woo; Soo-Geun Kim; Dong-Il Kim; Won Sool Kim; Byung-Seong Suh; Nam-Kyong Choi; Jong-Tae Lee
Journal:  J Am Soc Nephrol       Date:  2008-05-21       Impact factor: 10.121

4.  Body mass index in 1.2 million adolescents and risk for end-stage renal disease.

Authors:  Asaf Vivante; Eliezer Golan; Dorit Tzur; Adi Leiba; Amir Tirosh; Karl Skorecki; Ronit Calderon-Margalit
Journal:  Arch Intern Med       Date:  2012-11-26

5.  Obesity, Renin-Angiotensin System Blockade and Risk of Adverse Renal Outcomes: A Population-Based Cohort Study.

Authors:  Jordana B Cohen; Alisa J Stephens-Shields; Michelle R Denburg; Amanda H Anderson; Raymond R Townsend; Peter P Reese
Journal:  Am J Nephrol       Date:  2016-05-28       Impact factor: 3.754

6.  Obesity, metabolic health, and the risk of end-stage renal disease.

Authors:  Bhupesh Panwar; Lynae J Hanks; Rikki M Tanner; Paul Muntner; Holly Kramer; William M McClellan; David G Warnock; Suzanne E Judd; Orlando M Gutiérrez
Journal:  Kidney Int       Date:  2014-12-17       Impact factor: 10.612

Review 7.  The Centrality of Obesity in the Course of Severe COVID-19.

Authors:  Danfei Liu; Tongyue Zhang; Yijun Wang; Limin Xia
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-11       Impact factor: 5.555

Review 8.  Nephrology for the people: Presidential Address at the 42nd Regional Meeting of the Japanese Society of Nephrology in Okinawa 2012.

Authors:  Kunitoshi Iseki
Journal:  Clin Exp Nephrol       Date:  2013-02-08       Impact factor: 2.801

Review 9.  The insulin-like growth factor system in chronic kidney disease: Pathophysiology and therapeutic opportunities.

Authors:  Youngman Oh
Journal:  Kidney Res Clin Pract       Date:  2012-01-17

10.  The association of chronic kidney disease and waist circumference and waist-to-height ratio in Chinese urban adults.

Authors:  Yuan He; Fan Li; Fei Wang; Xu Ma; Xiaolan Zhao; Qiang Zeng
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.